Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Mycolic acids (MAs) are essential components of the Mycobacterium tuberculosis (M.tb) mycomembrane, contributing to bacterial survival, virulence, and drug resistance.
• While significant progress has been made in understanding MA biosynthesis, the precise roles of phosphorylation and dephosphorylation in regulating these pathways remain incompletely understood.
• Mycobacterium tuberculosis encodes 11 serine-threonine protein kinases (STPKs), and many enzymes in MA synthesis are known to be phosphorylated, affecting their activity.

Purpose of the Study:

• To review recent advancements in understanding the kinases and phosphatases that regulate mycolic acid biosynthesis in M.tb.
• To highlight the known small molecule inhibitors targeting these regulatory systems.
• To explore the potential of these mycobacterial kinases and phosphatases as therapeutic targets for tuberculosis.

Main Methods:

• Literature review of current research on M.tb mycolic acid biosynthesis regulation.
• Analysis of known phosphorylation sites and their impact on enzyme activity.
• Compilation of information on identified small molecule inhibitors.

Main Results:

• Phosphorylation generally downregulates key enzymes in MA synthesis (e.g., KasA, InhA, FadD32), while phosphorylation of VirS enhances its activity.
• These phosphorylation events suggest a regulatory role for kinases and phosphatases in M.tb adaptation and survival within the host.
• Mycobacterial STPKs exhibit low sequence homology to human kinases, making them attractive targets for selective drug development.

Conclusions:

• The intricate system of kinases and phosphatases regulating M.tb mycolic acid biosynthesis presents a viable target for novel antitubercular drug discovery.
• Targeting these enzymes could disrupt essential bacterial processes, leading to effective treatments for tuberculosis.